UK delivers COVID-19 vaccines to Antarctica to inoculate British researchers
A delivery of COVID-19 vaccines has arrived in Antarctica to inoculate British researchers stationed in the polar wilderness, the UK foreign ministry said Thursday.
The shipment was delivered to the British Antarctic Survey’s Rothera Research Station, making the outpost the furthest destination in the British Overseas Territories to be supplied with jabs.
The AstraZeneca shots were flown from a Royal Air Force base in Britain via Senegal and the Falklands Islands before reaching the 23-member staff at the facility in the British Antarctic Territory.
For more coronavirus news, visit our dedicated page.
The 10,000-mile (16,000-kilometre) journey across four continents concluded the UK government’s commitment to supply vaccines to all the inhabited UK Overseas Territories and was achieved in partnership with the international development organization, Crown Agents.
Crown Agents’ chief executive Fergus Drake said the organization had supplied the vaccines to “literally the ends of the earth,” including the Pitcairn Islands in the Pacific and Tristan da Cunha in the south Atlantic.
For the latest headlines, follow our Google News channel online or via the app.
Throughout the journey to the planet’s southernmost extremity, vaccines were transported at controlled temperatures to keep the doses at their required two to eight degrees Celsius (35.6 to 46.4 Fahrenheit).
The entire journey had to be carefully planned and executed to ensure the trip was completed in under 92 hours, to avoid spoilage of the vaccines.
Double doses of the vaccines will be available to the 23 members of the “overwintering” team at Rothera, which includes land and marine biologists, meteorologists, engineers, a dive officer, doctor, and chef.
Read more:
Pfizer, BioNTech ask US regulators to approve COVID-19 vaccine for kids
COVID-19 reinfection likely for unvaccinated: Study
WHO working to ship COVID-19 medical supplies to North Korea
-
AstraZeneca asks FDA to authorize COVID-19 antibody treatment
AstraZeneca, the drugmaker that developed one of the first COVID-19 vaccines, has asked the US Food and Drug Administration to authorize the emergency ... Coronavirus -
AstraZeneca boss Soriot says do not rush needlessly into COVID-19 jab booster: Report
AstraZeneca Plc Chief Executive Pascal Soriot said booster COVID vaccine doses may not be needed for everyone in Britain and rushing into a nationwide ... Coronavirus -
COVID-19: UK drops advice against non-urgent travel to 32 destinations
Britain dropped its advice against all but essential travel for 32 countries and territories on Wednesday as it continued to simplify its coronavirus ... Coronavirus -
At least one long-term symptom seen in a third of COVID-19 patients: UK study
More than a third of COVID-19 patients have shown at least one long-term symptom three to six months after being infected by the virus, according to a ... Coronavirus